scorecardresearch
Monday, September 8, 2025
TopicVaccine

Topic: Vaccine

Flagging bird flu’s ‘pandemic potential’, ICMR calls on private firms to collaborate on human vaccine

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 percent.

India’s Vaccine Regulation System Meets WHO Standards

A review was carried out by international experts between 16 and 20 September.

ICMR back in race to offer world’s 1st vaccine for deadly shigella, to tie up with Indian manufacturer

ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.

BRICS Vaccine Research Center launched in India

New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...

Government signs MoU with UNDP for capacity building and digitalization of vaccine cold chain management

This partnership aims to enhance the digitalization of vaccine cold chain management, capacity building, and communication planning in India.

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Global panel calls for scaling up cholera vaccine supply to combat ongoing upsurge in cases

International Coordinating Group (ICG) on Vaccine Provision (ICG) noted that 473,000 cases of cholera were reported to the WHO in 2022.

Govt for the first time considers pre-exposure anti-rabies shots for kids as dog bite cases ‘rise’

National Centre for Disease Control formed panel to discuss such vaccinations through Universal Immunization Programme. Evidence being gathered to present to NTAGI, it is learnt.

World’s 1st vaccine against chikungunya primed for launch in India, says French drugmaker Valneva

VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.

WHO recommends 2nd malaria vaccine — why Oxford-SII shot is likely to cost less, have wider reach

The R21 or Matrix-M vaccine has been developed by scientists at Oxford University & is the 2nd to receive WHO recommendation, after RTS,S or AS01 (brand name Mosquirix), approved in 2021.

On Camera

Don’t believe these 10 sunscreen myths

UV rays can penetrate through clouds and still cause skin damage even on overcast days. Sunscreen should be part of your routine throughout the year.

Punjab’s paddy farmers are staring at big losses. Why flood impact may spill out of India’s rice bowl

As devastated farmers begin to come to terms with the fallout, 4 lakh hectares of land under paddy cultivation across state is flooded. Punjab is among the biggest contributors to PDS.

Army chief weighs in on theaterisation, says it is inevitable and need of the hour

New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour. Speaking...

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?